Analysts Set Mereo BioPharma Group plc (NASDAQ:MREO) Target Price at $7.71
Mereo BioPharma Group plc (NASDAQ:MREO – Get Free Report) has been assigned a consensus rating of “Buy” from the eight brokerages that are currently covering the company, Marketbeat.com reports. Six research analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. The average twelve-month price […]
Mereo BioPharma Group plc (NASDAQ:MREO – Get Free Report) has been assigned a consensus rating of “Buy” from the eight brokerages that are currently covering the company, Marketbeat.com reports. Six research analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. The average twelve-month price […]
